{"name":"SR One","permalink":"sr-one","crunchbase_url":"http://www.crunchbase.com/financial-organization/sr-one","homepage_url":"http://www.srone.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"610.567.1000","description":"Venture Capital","email_address":"","number_of_employees":null,"founded_year":1985,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Tue Jun 16 06:24:27 UTC 2009","updated_at":"Tue Jun 16 06:37:22 UTC 2009","overview":"<p>SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in\nemerging life science companies that are pursuing innovative science which will significantly\nimpact medical care. Since 1985, SR One has invested approximately $600 million in more than\n130 companies. For more information please visit www.srone.com</p>","image":{"available_sizes":[[[150,58],"assets/images/resized/0004/8794/48794v2-max-150x150.jpg"],[[206,81],"assets/images/resized/0004/8794/48794v2-max-250x250.jpg"],[[206,81],"assets/images/resized/0004/8794/48794v2-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"HQ","address1":"161 Washington Street, Suite 500","address2":"Eight Tower Bridge ","zip_code":"19428-2077","city":"Conshohocken, ","state_code":"PA","country_code":"USA","latitude":40.071095,"longitude":-75.307827}],"relationships":[{"is_past":true,"title":"President, SR One","person":{"first_name":"Russell","last_name":"Greig","permalink":"russell-greig","image":{"available_sizes":[[[100,150],"assets/images/resized/0004/8798/48798v1-max-150x150.jpg"],[[144,216],"assets/images/resized/0004/8798/48798v1-max-250x250.jpg"],[[144,216],"assets/images/resized/0004/8798/48798v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":true,"title":"Partner","person":{"first_name":"Carol","last_name":"Ashe","permalink":"carol-ashe","image":{"available_sizes":[[[100,150],"assets/images/resized/0004/8799/48799v1-max-150x150.jpg"],[[144,216],"assets/images/resized/0004/8799/48799v1-max-250x250.jpg"],[[144,216],"assets/images/resized/0004/8799/48799v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"d","source_url":"http://www.zibb.com/article/5328061/Aileron+Therapeutics+Closes+Series+D+Financing?expired=4556347","source_description":"Aileron Therapeutics Closes Series D Financing","raised_amount":40000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":11,"company":{"name":"Aileron Therapeutic","permalink":"aileron-therapeutics","image":{"available_sizes":[[[150,87],"assets/images/resized/0004/8789/48789v1-max-150x150.png"],[[153,89],"assets/images/resized/0004/8789/48789v1-max-250x250.png"],[[153,89],"assets/images/resized/0004/8789/48789v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/calcimedica-inc-series-c-4m/","source_description":"CalciMedica, Inc.: Series C $4M","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":4,"company":{"name":"CalciMedica","permalink":"calcimedica","image":{"available_sizes":[[[150,35],"assets/images/resized/0004/8731/48731v1-max-150x150.jpg"],[[248,58],"assets/images/resized/0004/8731/48731v1-max-250x250.jpg"],[[248,58],"assets/images/resized/0004/8731/48731v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/anaphore-inc-series-a-13m/","source_description":"Anaphore, Inc.: Series A $13M","raised_amount":13000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":9,"company":{"name":"Anaphore","permalink":"anaphore","image":{"available_sizes":[[[150,37],"assets/images/resized/0004/7312/47312v2-max-150x150.png"],[[245,62],"assets/images/resized/0004/7312/47312v2-max-250x250.png"],[[245,62],"assets/images/resized/0004/7312/47312v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"","source_description":"Capital Funding Report","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":1,"funded_day":1,"company":{"name":"POINT Biomedical","permalink":"point-biomedical","image":{"available_sizes":[[[62,40],"assets/images/resized/0004/9270/49270v1-max-150x150.png"],[[62,40],"assets/images/resized/0004/9270/49270v1-max-250x250.png"],[[62,40],"assets/images/resized/0004/9270/49270v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://deals.venturebeat.com/2009/11/09/trinity-biosystems-raises-7-5m-bridge-to-treat-endocrine-disorders/","source_description":"Trinity Biosystems raises $7.5M bridge to treat endocrine disorders","raised_amount":7500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":9,"company":{"name":"Trinity Biosystems","permalink":"trinity-biosystems","image":{"available_sizes":[[[150,51],"assets/images/resized/0006/5604/65604v1-max-150x150.jpg"],[[223,77],"assets/images/resized/0006/5604/65604v1-max-250x250.jpg"],[[223,77],"assets/images/resized/0006/5604/65604v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2009/12/calcimedica-closes-second-tranche-of.html","source_description":"CalciMedica Closes Second Tranche of $12M Series C Financing","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":15,"company":{"name":"CalciMedica","permalink":"calcimedica","image":{"available_sizes":[[[150,35],"assets/images/resized/0004/8731/48731v1-max-150x150.jpg"],[[248,58],"assets/images/resized/0004/8731/48731v1-max-250x250.jpg"],[[248,58],"assets/images/resized/0004/8731/48731v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.syntaxin.com/biopharma-news-article.php?id=39","source_description":"Syntaxin Raises $32M to Advance Development of Novel Drug Pipeline","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":31,"company":{"name":"Syntaxin","permalink":"syntaxin","image":{"available_sizes":[[[150,64],"assets/images/resized/0008/0047/80047v1-max-150x150.jpg"],[[182,78],"assets/images/resized/0008/0047/80047v1-max-250x250.jpg"],[[182,78],"assets/images/resized/0008/0047/80047v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.onyvax.com/html/press_releases/1/2006_05_08_Fundraising.html","source_description":"Onyvax Raises Â£8 Million to Advance Development of Prostate Cancer Vaccine","raised_amount":8000000,"raised_currency_code":"GBP","funded_year":2006,"funded_month":5,"funded_day":8,"company":{"name":"Onyvax","permalink":"onyvax","image":{"available_sizes":[[[150,47],"assets/images/resized/0008/4586/84586v1-max-150x150.jpg"],[[210,66],"assets/images/resized/0008/4586/84586v1-max-250x250.jpg"],[[210,66],"assets/images/resized/0008/4586/84586v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/big-pharma-groups-back-43m-round-neurotherapeutics/2010-05-20?utm_medium=rss&utm_source=rss","source_description":"Big Pharma firms back $43M round for NeuroTherapeutics","raised_amount":43000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":20,"company":{"name":"NeuroTherapeutics Pharma","permalink":"neurotherapeutics-pharma","image":{"available_sizes":[[[150,45],"assets/images/resized/0008/8127/88127v1-max-150x150.jpg"],[[250,76],"assets/images/resized/0008/8127/88127v1-max-250x250.jpg"],[[318,97],"assets/images/resized/0008/8127/88127v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://onbiovc.com/constellation-pharmaceuticals-inc-series-b-48m/","source_description":"Constellation Pharmaceuticals, Inc.: Series B $4.8M","raised_amount":4800000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":7,"company":{"name":"Constellation Pharmaceuticals","permalink":"constellation-pharmaceuticals","image":{"available_sizes":[[[150,62],"assets/images/resized/0006/2182/62182v1-max-150x150.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-250x250.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29&aid=DJFVLS0020100908e6990008d&r=Rss&s=DJFVLS","source_description":"IPierian Announces Second Close Of Series B Financing At $28M  ","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":9,"company":{"name":"iPierian","permalink":"ipierian","image":{"available_sizes":[[[142,99],"assets/images/resized/0006/0988/60988v1-max-150x150.png"],[[142,99],"assets/images/resized/0006/0988/60988v1-max-250x250.png"],[[142,99],"assets/images/resized/0006/0988/60988v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.masshightech.com/stories/2010/10/18/daily46-Dicerna-makes-29M-second-close-on-Series-B-funding-round.html","source_description":"Dicerna makes $29M second close on Series B funding round","raised_amount":4000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":10,"funded_day":21,"company":{"name":"Dicerna Pharmaceuticals","permalink":"dicerna-pharmaceuticals","image":{"available_sizes":[[[150,56],"assets/images/resized/0007/2125/72125v1-max-150x150.jpg"],[[227,86],"assets/images/resized/0007/2125/72125v1-max-250x250.jpg"],[[227,86],"assets/images/resized/0007/2125/72125v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/vcs-inject-29m-syntaxin-115m-ceregene/2010-11-11?utm_medium=rss&utm_source=rss","source_description":"VCs inject $29M into Syntaxin, $11.5M into Ceregene","raised_amount":29000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":11,"funded_day":11,"company":{"name":"Syntaxin","permalink":"syntaxin","image":{"available_sizes":[[[150,64],"assets/images/resized/0008/0047/80047v1-max-150x150.jpg"],[[182,78],"assets/images/resized/0008/0047/80047v1-max-250x250.jpg"],[[182,78],"assets/images/resized/0008/0047/80047v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.semprusbio.com/documents/SEMPRUS_BIOSCIENCES_RAISES_ADDITIONAL_18_MILLION.pdf","source_description":"SEMPRUS BIOSCIENCES RAISES ADDITIONAL $18 MILLION","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":12,"funded_day":13,"company":{"name":"Semprus BioSciences","permalink":"semprus-biosciences","image":{"available_sizes":[[[150,36],"assets/images/resized/0004/9007/49007v1-max-150x150.jpg"],[[244,59],"assets/images/resized/0004/9007/49007v1-max-250x250.jpg"],[[244,59],"assets/images/resized/0004/9007/49007v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/01/genocea-biosciences-closes-35m-series-b.html","source_description":"Genocea Biosciences Closes $35M Series B Financing Round","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":3,"company":{"name":"Genocea Biosciences","permalink":"genocea-biosciences","image":{"available_sizes":[[[150,63],"assets/images/resized/0009/8416/98416v1-max-150x150.png"],[[250,106],"assets/images/resized/0009/8416/98416v1-max-250x250.png"],[[256,109],"assets/images/resized/0009/8416/98416v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.masshightech.com/stories/2011/05/09/daily34-SpringLeaf-Therapeutics-raises-15M-Series-B-round.html","source_description":"SpringLeaf Therapeutics raises $15M Series B round","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":12,"company":{"name":"Springleaf Therapeutics","permalink":"springleaf-therapeutics","image":{"available_sizes":[[[150,48],"assets/images/resized/0013/4279/134279v1-max-150x150.jpg"],[[250,80],"assets/images/resized/0013/4279/134279v1-max-250x250.jpg"],[[327,105],"assets/images/resized/0013/4279/134279v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/06/constellation-pharmaceuticals-raises-15m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Constellation Pharmaceuticals Raises $15M in Series B Financing","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":6,"company":{"name":"Constellation Pharmaceuticals","permalink":"constellation-pharmaceuticals","image":{"available_sizes":[[[150,62],"assets/images/resized/0006/2182/62182v1-max-150x150.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-250x250.jpg"],[[231,96],"assets/images/resized/0006/2182/62182v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2011/06/htg-molecular-diagnostics-receives-500k-sr-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"HTG Molecular Diagnostics Receives $500k from SR One in Series D Financing","raised_amount":500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":13,"company":{"name":"HTG Molecular Diagnostics","permalink":"htg-molecular-diagnostics","image":{"available_sizes":[[[150,89],"assets/images/resized/0013/8983/138983v1-max-150x150.jpg"],[[150,89],"assets/images/resized/0013/8983/138983v1-max-250x250.jpg"],[[150,89],"assets/images/resized/0013/8983/138983v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.xconomy.com/boston/2011/06/28/nimbus-seeded-by-bill-gates-raises-24-million-for-computer-aided-drug-discovery/","source_description":"Nimbus, Seeded by Bill Gates, Raises $24 Million For Computer-Aided Drug Discovery","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":28,"company":{"name":"Nimbus Discovery","permalink":"nimbus-discovery","image":{"available_sizes":[[[148,110],"assets/images/resized/0012/5898/125898v1-max-150x150.png"],[[148,110],"assets/images/resized/0012/5898/125898v1-max-250x250.png"],[[148,110],"assets/images/resized/0012/5898/125898v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.f-star.com/fstarPressRelease_3.pdf","source_description":"f-star raises â‚¬15M in a New Financing led by SR One","raised_amount":15000000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":4,"funded_day":13,"company":{"name":"f-star Biotech","permalink":"f-star-biotechnologische-forschungs-und-entwicklungsges-m-b-h","image":{"available_sizes":[[[148,150],"assets/images/resized/0007/2453/72453v1-max-150x150.jpg"],[[148,150],"assets/images/resized/0007/2453/72453v1-max-250x250.jpg"],[[148,150],"assets/images/resized/0007/2453/72453v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.biospace.com/News/cambridge-spin-out-mission-therapeutics-raises-10/231199","source_description":"MissionTherapeutics Ltd Raises $10 Million, Eyes Rapid Growth","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":25,"company":{"name":"MISSION Therapeutics","permalink":"mission-therapeutics","image":{"available_sizes":[[[150,65],"assets/images/resized/0015/1183/151183v1-max-150x150.jpg"],[[250,108],"assets/images/resized/0015/1183/151183v1-max-250x250.jpg"],[[255,111],"assets/images/resized/0015/1183/151183v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.masshightech.com/stories/2012/01/16/daily14-RaNA-Therapeutics-emerges-from-stealth-with-207M-Series-A-round.html","source_description":"RaNA Therapeutics emerges from stealth with $20.7M Series A round","raised_amount":20700000,"raised_currency_code":"USD","funded_year":2012,"funded_month":1,"funded_day":18,"company":{"name":"RaNA Therapeutics","permalink":"rana-therapeutics","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2012/06/auxogyn-raises-18m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Auxogyn Raises $18M in Series B Financing","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":5,"company":{"name":"Auxogyn","permalink":"auxogyn","image":{"available_sizes":[[[117,112],"assets/images/resized/0017/2764/172764v1-max-150x150.png"],[[117,112],"assets/images/resized/0017/2764/172764v1-max-250x250.png"],[[117,112],"assets/images/resized/0017/2764/172764v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.marketwire.com/press-release/illuminoss-medical-secures-28-million-series-c-financing-minimally-invasive-bone-fracture-nyse-hqh-1706365.htm","source_description":"IlluminOss Medical Secures $28 Million Series C Financing for Minimally Invasive Bone Fracture Repair","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":27,"company":{"name":"IlluminOss Medical","permalink":"illuminoss-medical","image":{"available_sizes":[[[150,45],"assets/images/resized/0016/4547/164547v1-max-150x150.jpg"],[[250,75],"assets/images/resized/0016/4547/164547v1-max-250x250.jpg"],[[328,99],"assets/images/resized/0016/4547/164547v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.masshightech.com/stories/2012/10/08/daily28-Genocea-raises-30M-to-advance-herpes-vaccine.html","source_description":"Genocea raises $30M to advance herpes vaccine","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":10,"company":{"name":"Genocea Biosciences","permalink":"genocea-biosciences","image":{"available_sizes":[[[150,63],"assets/images/resized/0009/8416/98416v1-max-150x150.png"],[[250,106],"assets/images/resized/0009/8416/98416v1-max-250x250.png"],[[256,109],"assets/images/resized/0009/8416/98416v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.businesswire.com/news/edmontonjournal/20121025005392/en/Thrasos-Secures-35-Million-Fund-THR-184-Phase","source_description":"Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":25,"company":{"name":"Thrasos","permalink":"thrasos","image":{"available_sizes":[[[150,56],"assets/images/resized/0021/7327/217327v1-max-150x150.jpg"],[[250,94],"assets/images/resized/0021/7327/217327v1-max-250x250.jpg"],[[252,95],"assets/images/resized/0021/7327/217327v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.bizjournals.com/sacramento/prnewswire/press_releases/California/2012/10/29/NY01747","source_description":"Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team","raised_amount":12500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":29,"company":{"name":"Principia BioPharma","permalink":"principia-biopharma","image":{"available_sizes":[[[150,31],"assets/images/resized/0021/7842/217842v1-max-150x150.jpg"],[[250,52],"assets/images/resized/0021/7842/217842v1-max-250x250.jpg"],[[394,82],"assets/images/resized/0021/7842/217842v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}